Revolution Medicines Inc. (RVMD) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Revolution Medicines Inc.

    NASDAQ: RVMD · Real-Time Price · USD
    40.50
    1.55 (3.98%)
    At close: Sep 05, 2025, 3:59 PM
    40.55
    0.13%
    Pre-market: Sep 08, 2025, 08:00 AM EDT

    Revolution Medicines Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a 11.58M 35.38M 29.39M
    Cost of Revenue
    		 592.23M 411.24M 253.07M 186.95M
    Gross Profit
    		 -592.23M -399.66M -217.69M -157.56M
    Operating Income
    		 -689.52M -487.19M -258.28M -188.01M
    Interest Income
    		 86.88M 47.48M 9.15M 929K
    Pretax Income
    		 -600.85M -439.89M -249.13M -187.09M
    Net Income
    		 -600.09M -436.37M -248.71M -187.09M
    Selling & General & Admin
    		 97.3M 62.02M 40.59M 30.45M
    Research & Development
    		 592.23M 423.14M 253.07M 186.95M
    Other Expenses
    		 -592.23M -397.64M -253.07M -186.95M
    Operating Expenses
    		 97.3M 87.52M 40.59M 30.45M
    Interest Expense
    		 n/a n/a n/a 12K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 689.52M 498.76M 293.66M 217.4M
    Income Tax Expense
    		 753K -3.52M -420K n/a
    Shares Outstanding (Basic)
    		 167.74M 113.15M 80.63M 72.81M
    Shares Outstanding (Diluted)
    		 167.74M 113.15M 80.63M 72.81M
    EPS (Basic)
    		 -3.58 -3.86 -3.08 -2.47
    EPS (Diluted)
    		 -3.58 -3.86 -3.08 -2.47
    EBITDA
    		 -589.02M -456.68M -248.62M -179.75M
    EBIT
    		 -600.85M -461.69M -258.28M -187.08M
    Depreciation & Amortization
    		 11.82M 5.01M 9.66M 7.33M

    Add to Watchlist